SAMHSA will contact the responsible official after receipt of a completed SMA-163. Existing Accreditation Bodies (ABs) wishing to submit
Any deviation from the opioid treatment standards in 42 CFR 8 requires the submission and approval of the Form SMA-168 exception request. to OTPs during the accreditation process; policies and procedures for notifying
If there is none include a statement. print
A registered staff person may initiate and fill out an exception request, but only a registered physician or an approved exempted practitioner ( https://otp-extranet.samhsa.gov/login.aspx ) may approve and execute the submission. Select "Logout" below if you are ready to end your current session. This system is provided for Government-authorized use only. SAMHSA
Special characters can be symbols on your keyboard (e.g. Best viewed in IE 8.0 or above in screen resolution 1024 by 768 pixels. Learn about the federal statutes, regulations, and guidelines that apply to medications for opioid use disorders (MOUD) for practitioners and opioid treatment programs (OTPs). Include a chart indicating the position and title of key personnel of the OTP, which includes the name and complete address of any central administration or larger organizational structure to which this program is responsible. NAMI, the National Alliance on Mental Illness, is the nation's largest grassroots mental health organization dedicated to building better lives for the millions of Americans affected by mental illness. This form must be submitted via the SAMHSA OTP Extranet website for review by both the state opioid treatment authority and SAMHSA. SAMHSA collects data through multiple sources and surveys and provides access to public-use data files and documentation to support a better understanding of mental illness and substance use disorders in America. We apologize for any inconvenience. To sign up for updates or to access your subscriber preferences, please enter your contact information. hb```nB ce`aX$0m
J6U?\?D`ynE%)6,&8
g3:uLdGJ>l{(U&%*Q
%)U+g9:7t.
NZHJ`+f0)A
qT8:-f"G Gq#by7CY0312ng$XlXln,e7sNoCjui3M+c
. The submission process will not be complete until the Sponsor clicks the link in that e-mail. away from the primary dispensing site, should also be stated. Data for ED visits include demographics, substances involved, toxicology confirmation, route of administration, type of case, and disposition of the patient following their visit. A description of the education, experience, and training requirements for the accreditation
Laboratory Web Portal . Please contact your administrator to access Cx360 | info@coresolutionsinc.com. Personal use of social media and networking sites on this system is limited as to not interfere with official work duties and is subject to monitoring. SAMHSA's mission is to reduce the impact of substance abuse and mental illness on America's communities. Personal use of social media and networking sites on this system is limited as to not interfere with official work duties and is subject to monitoring. SAMHSA.gov, Material Abuse and Mental Health Auxiliary Administration. Welcome to the new Center for Behavioral Health Statistics and Quality (CBHSQ) data page! Substance Abuse and Mental Health Services Administration. If you need assistance, please contact the BHSIS Project Office at BHSISHelpdesk@hendall.com or 1-833-888-1553. Therefore, you have no reasonable expectation of privacy regarding any communication or data transiting or stored on this system. OTP Extranet Access. Enter query . That violation may threaten a programs federal and state compliance, accreditation, and certification. After the request is verified, the applicant will receive an email with a username and password for use of the website. Note: Only initial approval to serve as an accreditation body
Login. under 42 CFR 8.4 (e). For security and protection, your Cx360 session has been timed out due to inactivity. At any time, and for any lawful Government purpose, the government may monitor, intercept, and search and seize any communication or data transiting or stored on this system. Any communication or data transiting or stored on this system may be disclosed or used for any lawful Government purpose. endstream
endobj
startxref
A tentative schedule showing (1) dispensing hours, (2) counseling hours, and (3)
Name and State license number of all OTP personnel (other than program physicians) licensed by law to dispense narcotic drugs even if they are not, at present, responsible for administering or dispensing methadone at the program. Also, describe how the dispensing
The Treatment Episode Data SetAdmissions (TEDS-A) is a national data system of annual admissions to substance use treatment facilities. complete the submission process. This warning banner provides privacy and security notices consistent with applicable federal laws, directives, and other federal guidance for accessing this Government system, which includes (1) this computer network, (2) all computers connected to this network, and (3) all devices and storage media attached to this network or to a computer on this network. Any communication or data transiting or stored on this system may be disclosed or used for any lawful Government purpose. By using this system, you understand and consent to the following: Note: OTP Extranet is using the HHS password security requirements. User Name: *. At this time, SOTAs across . We recommend that you obtain and
Find contact information for State Opioid Treatment Authorities. Visit SAMHSA on Twitter 1-877-SAMHSA-7 (1-877-726-4727), Elinore McCance-Katz, M.D., Ph.D., Assistant Secretary for Mental Health and Substance Use. Exceptions can only be submitted by an OTPs qualifying practitioner(s) who have submitting and approval authority. Login to the Extranet website to access Form SMA-168. A list of the programs funding sources , including the name and address of each governmental agency providing funds. Existing OTPs wishing to submit
A detailed labeled floor diagram. Meaning. a description of the accreditation bodys training policies and survey fee schedules
Welcome to I-TF. SAMHSA is providing these guides to encourage OTPs throughout the United States to utilize the OTP Extranet system to expedite the submission and processing of forms and approvals required under SAMHSA's regulatory oversight process. SMA-163, a confirmation e-mail will be sent to the responsible official. On occasion, patients in opioid treatment programs (OTPs) may need exceptions from the federal opioid treatment standards. If you are having difficulty submitting changes or have questions, contact the CSAT Buprenorphine Information Center at 866-BUP-CSAT (866-287-2728), or by e-mail at infobuprenorphine@samhsa.hhs.gov. Provides planning and management of program evaluation across SAMHSA.
You may wish to
This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional. Forgot User Password? application for provisional certification of a new OTP. The users are now asked to change their passwords every 2 months, and the passwords have to be strong,
SAMHSA's mission is to reduce the impact of substance abuse and mental illness on America's communities. This warning banner provides privacy and security notices consistent with applicable federal laws, directives, and other federal guidance for accessing this Government system, which includes (1) this computer network, (2) all computers connected to this network, and (3) all devices and storage media attached to this network or to a computer on this network. Results from the 2021 National Survey on Drug Use and Health, Findings from Drug-Related Emergency Department Visits, 2021, Data on Substance Use and Mental Health Treatment Facilities, 2021. For assistance with the Opioid Treatment Program Extranet, contact the OTP helpdesk at OTP-Help@jbsinternational.com or 1-866-348-5741. Privacy Policy Common reasons include transportation hardships, conflicts with employment or vacation, and medical disabilities, etc. hours to be worked by physicians, nurses, and counselors. with your online SMA-163. new search. All Rights Reserved. can be processed expeditiously by SAMHSA. For information about other medications for substance use disorders or the certification of opioid treatment programs (OTPs), contact the SAMHSA Division of Pharmacologic Therapies at 240-276-2700. The responsible officials name and contact information, including telephone
1-877-SAMHSA-7 (1-877-726-4727), Opioid Treatment Providers Resources and Information, SAMHSA.gov, Substance Abuse and Mental Health Services Administration, Buprenorphine Physician & Treatment Program Locator, Early Serious Mental Illness Treatment Locator, View All Helplines and Treatment Locators, Implementing Behavioral Health Crisis Care, Mental Health and Substance Use Disorders, Substance Abuse and Mental Health Prevention, Technology Transfer Centers (TTC) Program, State Targeted Response Technical Assistance (STR-TA), Clinical Support System for Serious Mental Illness (CSS-SMI), Suicide Prevention Resource Center (SPRC), African American Behavioral Health Center of Excellence, Asian American, Native Hawaiian, and Pacific Islander Behavioral Health Center of Excellence (AANHPI-CoE), Center of Excellence for Building Capacity in Nursing Facilities to Care for Residents with Behavioral Health Conditions, Center of Excellence for Protected Health Information (CoE-PHI), Center of Excellence on Social Media and Mental Wellbeing (SMMW-CoE), Rural Opioid Technical Assistance Regional Centers (ROTA-R), Engage, Educate, Empower for Equity: E4 Center of Excellence for Behavioral Health Disparities in Aging, LGBTQ+ Behavioral Health Equity Center of Excellence, National Center of Excellence for Eating Disorders (NCEED), National Center of Excellence for Tobacco-Free Recovery, National Center on Substance Abuse and Child Welfare (NCSACW), National Family Support Technical Assistance Center (NFSTAC), National Institutes of Health (NIH) Training Resources, National Training and Technical Assistance Center for Child, Youth, and Family Mental Health, Providers Clinical Support SystemUniversities, Tribal Training and Technical Assistance Center, National Center of Excellence for Integrated Health Solutions, Mental Illness and Substance Use in Young Adults, Resources for Families Coping with Mental and Substance Use Disorders, Screening and Treatment of Co-Occurring Disorders, FY 2020 Funding Announcements and Grant Awards, FY 2021 Funding Announcements and Grant Awards, FY 2019 Funding Announcements and Grant Awards, FY 2018 Funding Announcements and Grant Awards, FY 2017 Funding Announcements and Grant Awards, FY 2016 Funding Announcements and Grant Awards, FY 2015 Funding Announcements and Grant Awards, FY 2014 Funding Announcements and Grant Awards, FY 2013 Funding Announcements and Grant Awards, FY 2012 Funding Announcements and Grant Awards, FY 2011 Funding Announcements and Grant Awards, FY 2010 Funding Announcements and Grant Awards, FY 2009 Funding Announcements and Grant Awards, FY 2008 Funding Announcements and Grant Awards, FY 2007 Funding Announcements and Grant Awards, FY 2006 Funding Announcements and Grant Awards, FY 2005 Funding Announcements and Grant Awards, National Survey of Substance Abuse Treatment Services, Evidence-Based Practices (EBP) Resource Center, Interagency Task Force on Trauma-Informed Care, Protection & Advocacy for Individuals with Mental Illness (PAIMI) Program, Asian American, Native Hawaiian, and Pacific Islander, Disaster Preparedness, Response, and Recovery, Qualitative and Quantitative Assessment Methods, Early Serious Mental Illness (ESMI) Treatment Locator, Faith-Based and Community Initiatives (FBCI), Historically Black Colleges and Universities Center of Excellence in Behavioral Health, Mental and Substance Use Disorders and Homelessness Resources, Medications, Counseling, and Related Conditions, Pharmacist Verification of Buprenorphine Providers, Become an Accredited and Certified Opioid Treatment Program (OTP), Buprenorphine Dispensing by Opioid Treatment Programs (OTPs), Become a SAMHSA-Approved Opioid Treatment Program (OTP) Accrediting Body, Submit an Opioid Treatment Exception Request, Notify SAMHSA of Opioid Treatment Program (OTP) Changes, About SAMHSAs Division of Pharmacologic Therapies (DPT), Mental Health Awareness and Training Grant (MHAT), National Child Traumatic Stress Initiative (NCTSI), Recognizing and Treating Child Traumatic Stress, Entendamos el estrs traumtico infantil y cmo ayudar, National Children's Mental Health Awareness Day, National Consumer and Consumer Supported Technical Assistance Center (NCTAC), National Network to Eliminate Disparities in Behavioral Health (NNED), Networking, Certifying, and Training Suicide Prevention Hotlines and the Disaster Distress Helpline, Screening, Brief Intervention, and Referral to Treatment, Substance Use Disorder Treatment Providers, Person- and Family-centered Care and Peer Support, Care Provision, Coordination, and Patient Privacy, Developing a Continuity of Operations Plan, Comparta los resultados y retroalimentacin, The Interagency Coordinating Committee on the Prevention of Underage Drinking (ICCPUD), The Power of Perceptions and Understanding, What You Can Do To Prevent Your Child From Drinking, Why You Should Talk With Your Child About Alcohol and Other Drugs, Why Small Conversations Make a Big Impression, How To Tell If Your Child Is Drinking Alcohol, COVID-19 Information for SAMHSA Discretionary Grant Recipients, Training and Technical Assistance Related to COVID-19, Listening Session Comments on Substance Abuse Treatment Confidentiality Regulations, Advisory Committee for Womens Services (ACWS), Tribal Technical Advisory Committee (TTAC), Interdepartmental Serious Mental Illness Coordinating Committee (ISMICC), Interdepartmental Substance Use Disorders Coordinating Committee (ISUDCC), Interdepartmental Substance Use Disorders Coordinating Committee Biographical Information, Interdepartmental Substance Use Disorders Coordinating Committee Roster, Buprenorphine Quick Start Guide (PDF | 1.4 KB), new guidelines for practitioners who wish to prescribe buprenorphine for the treatment of OUD, SAMHSAs Division of Pharmacologic Therapies, U.S. Department of Health & Human Services.